View More Recent Stories

Apr 16, 2018 01:00AM Genentech to Present New Data at AAN Highlighting Extensive Research for OCREVUS and Expanding Neuroscience Pipeline
Jan 8, 2018 01:00AM GE, Roche Enter Partnership to Develop Integrated Digital Diagnostics Platform to Improve Oncology and Critical Care Treatment
Nov 1, 2017 12:30PM Genentech to Present New Data Across a Range of Blood Diseases at the American Society of Hematology (ASH) 2017 Annual Meeting
Oct 27, 2017 01:00AM New OCREVUS (Ocrelizumab) Data at ECTRIMS Advance Clinical Understanding of Underlying Progression in Multiple Sclerosis
Oct 16, 2017 01:00AM Genentech to Present New OCREVUS (Ocrelizumab) Efficacy & Safety Data in Relapsing and Primary Progressive Forms of Multiple Sclerosis at ECTRIMS
Jun 23, 2017 06:17AM Genentech (RHHBY) Says New Data at EAN Shows Ocrevus Reduced Disease Progression in RMS and PPMS
Jun 23, 2017 01:00AM New Data at EAN Show Genentech’s Ocrevus (Ocrelizumab) Significantly Reduced Multiple Measures of Disease Progression in Relapsing and Primary Progressive Multiple Sclerosis
May 11, 2017 01:00AM Genentech to Present New Data on Personalized Medicines and Cancer Immunotherapies at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting
Apr 26, 2017 01:00AM New Data at AAN Reinforce Clinical Benefit of Genentech’s OCREVUS (Ocrelizumab) for Relapsing and Primary Progressive Multiple Sclerosis
Apr 19, 2017 01:00AM Genentech to Present New Data at AAN Reinforcing Efficacy and Safety of Newly FDA Approved OCREVUS (Ocrelizumab) in Two Types of Multiple Sclerosis
Nov 3, 2016 12:30PM Genentech Showcases New Clinical Data across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
Nov 2, 2016 06:27AM Genentech (RHHBY) Plans Presentation of New Actemra, Rituxan Data at 2016 ACR/ARHP Annual Meeting
Nov 2, 2016 01:00AM Genentech to Present New Data on Medicines for Autoimmune Diseases and Severe Inflammatory Disorders at the 2016 ACR/ARHP Annual Meeting
Sep 14, 2016 06:22AM Roche's (RHHBY) Genentech Announces New Data from OCREVUS Phase 3 in MS
Sep 14, 2016 02:00AM Phase III Efficacy Results of Investigational Medicine OCREVUS™ (Ocrelizumab) Reinforced by Exploratory Analyses in Two Forms of Multiple Sclerosis
May 3, 2016 01:00AM Genentech Highlights Personalized Medicines and Cancer Immunotherapies at 2016 American Society of Clinical Oncology (ASCO) Annual Meeting
Apr 12, 2016 01:17PM Genentech to Present New Data at AAN Showing Superior Efficacy of Investigational Medicine Ocrelizumab Versus Comparators on Disease Activity and Progression in Two Forms of Multiple Sclerosis
Nov 5, 2015 11:52AM Genentech to Present New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2015 Annual Meeting
Oct 8, 2015 11:30AM Genentech’s Ocrelizumab First Investigational Medicine to Show Positive Pivotal Study Results in Both Relapsing and Primary Progressive Forms of Multiple Sclerosis
Sep 8, 2015 01:00AM Genentech to Present Data from 15 Medicines Across Its Portfolio of Cancer Immunotherapy and Targeted Medicines During the 2015 European Cancer Congress
May 11, 2015 01:00AM Pivotal Data for Genentech Medicines in Lung and Blood Cancers to Be Presented at ASCO
Jul 28, 2014 05:11PM Trading Radar for 07/29: Pfizer (PFE), Marriott (MAR), UPS (UPS), Anadarko (APC), Ballard Power (BLDP) Report
Jul 18, 2014 09:22AM Pre-Open Stock Movers 7/18: (ICLD) (GTIV) (SWKS) (GOOG) Higher; (RP) (NQ) (AMD) Lower (more...)
Jul 17, 2014 06:05PM After-Hours Stock Movers 7/17: (SWSK) (GOOG) (AVGO) Higher; (AMD) (STX) (IBM) Lower (more...)
Apr 28, 2014 02:28PM Trading Radar for 04/29: eBay (EBAY), Twitter (TWTR), Nokia (NOK), Express Scripts (ESRX), Seagate (STX) Report
View More Recent Stories